成人における全膝関節置換術後の血栓予防におけるREGN7508とアピキサバンおよびエノキサパリンの比較

基本情報

NCT ID

NCT07015905

ステータス

募集中

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

2,000

治験依頼者名

Regeneron Pharmaceuticals

概要

This study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing venous thromboembolism (VTE) and other related diseases after total knee replacement surgery. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug * How much study drug is in the blood at different times * Whether the body makes antibodies against the study drug (which could make the study drug less effective or could lead to side effects)

対象疾患

介入

依頼者（Sponsor）

実施施設 (7)